CSL Ltd (CSL)

Currency in AUD
267.92
-1.64(-0.61%)
Closed·
CSL Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
CSL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
267.15270.42
52 wk Range
228.61313.25
Key Statistics
Bid/Ask
267.70 / 268.98
Prev. Close
269.56
Open
269.56
Day's Range
267.15-270.42
52 wk Range
228.61-313.25
Volume
954.04K
Average Volume (3m)
802.08K
1-Year Change
-13.33%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CSL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
306.51
Upside
+14.40%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

CSL Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

CSL Ltd Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Employees
32698
Market
Australia

Compare CSL to Peers and Sector

Metrics to compare
CSL
Peers
Sector
Relationship
P/E Ratio
30.8x28.2x−0.5x
PEG Ratio
2.770.490.00
Price/Book
4.6x2.7x2.6x
Price / LTM Sales
5.6x3.8x3.2x
Upside (Analyst Target)
14.7%20.0%40.5%
Fair Value Upside
Unlock15.3%4.4%Unlock

Analyst Ratings

15 Buy
2 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 306.51
(+14.40% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.68%
Dividend Yield
1.58%
Industry Median 1.75%
Annualised payout
4.25
Paid unevenly
5-Years Growth
+7.12%
Growth Streak

Earnings

Latest Release
Feb 10, 2025
EPS / Forecast
4.13 / 4.50
Revenue / Forecast
8.48B / 8.019B
EPS Revisions
Last 90 days

CSL Income Statement

People Also Watch

40.800
BHP
-1.92%
604.90
ASML
-1.79%
118.860
RIO
-0.83%
30.220
ANZ
-0.72%
214.150
MQG
+0.14%

FAQ

What Stock Exchange Does CSL Trade On?

CSL is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for CSL?

The stock symbol for CSL is "CSL."

What Is the CSL Market Cap?

As of today, CSL market cap is 129.73B.

What Is CSL's Earnings Per Share (TTM)?

The CSL EPS (TTM) is 5.68.

From a Technical Analysis Perspective, Is CSL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has CSL Stock Split?

CSL has split 1 times.

How Many Employees Does CSL Have?

CSL has 32698 employees.

What is the current trading status of CSL (CSL)?

As of 25 Jul 2025, CSL (CSL) is trading at a price of 267.92, with a previous close of 269.56. The stock has fluctuated within a day range of 267.15 to 270.42, while its 52-week range spans from 228.61 to 313.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.